Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial

OBJECTIVE: Linagliptin, a dipeptidyl peptidase-4 inhibitor, recently demonstrated cardiovascular (CV) safety versus placebo in Asians with advanced type 2 diabetes mellitus (T2DM) in the CARMELINA(®) trial. We assessed its CV safety compared with the sulfonylurea glimepiride in Asians with relativel...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetol Int
Main Authors: Kadowaki, Takashi, Wang, Guang, Rosenstock, Julio, Yabe, Daisuke, Peng, Yongde, Kanasaki, Keizo, Mu, Yiming, Mattheus, Michaela, Keller, Annett, Okamura, Tomoo, Johansen, Odd Erik, Marx, Nikolaus
Format: Artigo
Sprog:Inglês
Udgivet: Springer Singapore 2020
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7790983/
https://ncbi.nlm.nih.gov/pubmed/33479584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-020-00447-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker